GSK reaches exclusive deal for technology developed by UNC spinout – Triangle Business Journal


Triangle Business Journal

GSK reaches exclusive deal for technology developed by UNC spinout
Triangle Business Journal
GlaxoSmithKline (NYSE: GSK) exercised an option that gives the company the exclusive rights to nearly all inhaled uses of a particle manipulating technology developed by Research Triangle Park-based Liquidia Technologies.

and more »

————————————
Read more at http://ift.tt/1JDCqfr